Review
Open access
Sep 2026
Age moderates the relationship between psychedelic use and mental health in naturalistic settings
Depression and anxiety affect one in five adults and vary across the lifespan; while prevalence generally declines with age until midlife, later life is marked by a re-emergence of symptoms. Although clinical trials suggest classic psychedelics (e.g., psilocybin, LSD) and non-classic psychedelics (e.g., MDMA, ketamin...
Giammarco Di Gregorio, Sophia Basset, Harjot Manmohan et al.
· Scientific Reports · 0 citations